DANIELLE DUNYO: Open Payments
NPI 1962166959 · WELDON SPRING, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,033 in 378 payments from 21 companies in 2025. Trend: 2023 $3,522 · 2024 $4,910 · 2025 $5,033
Food & beverage: $4,506Consulting: $463Education: $65
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 41 | $678 |
| Vanda Pharmaceuticals Inc. | 53 | $647 |
| ABBVIE INC. | 57 | $480 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 | $479 |
| Neurocrine BioSciences, Inc. | 28 | $425 |
| Corium, LLC | 35 | $390 |
| Otsuka America Pharmaceutical, Inc. | 37 | $365 |
| Axsome Therapeutics, Inc. | 27 | $299 |
| E.R. Squibb & Sons, L.L.C. | 15 | $199 |
| Supernus Pharmaceuticals, Inc. | 20 | $195 |
Products named: CAPLYTA, FANAPT, VRAYLAR, REXULTI, INGREZZA, Azstarys, Auvelity, COBENFY.
Industry payments across MO — which companies pay providers there.
